412-246-6111

 

Buprenorphine for Treatment Resistant Depression

(BUP- TRD)

 

  

Home     Depression     Bipolar Disorder     Cognitive Therapy     Research     Staff     Contact    TV ADs
 

 

Current Studies

Depression:

* Insomnia & Depression

* Transcranial Magnetic Stimulation (TMS)

* New Medication Trial (ROCHE)

* Buprenorphine for TRD

* New Medication Trial (Shire)

Assessment Only:

* Emotion/Physiology

Bipolar Disorder:

* Quetiapine vs. Lithium

  

*Please note enrollment is not yet open for this study*

Purpose

The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD).

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Buprenorphine For Treatment Resistant Depression

Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

 

For further information please call 412-246-6111, click here to email us, or visit clinicaltrials.gov.

 

  
 

If you have any questions or comments about this web site, please contact the webmaster.  For all other questions please click the contact link.

This website was last updated 06/14/2012.

© 2005 Mood Disorders Treatment and Research Program (MDTRP), Department of Psychiatry, Western Psychiatric Institute and Clinic (WPIC), UPMC Health System